You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Profile for Japan Patent: 6438071


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6438071

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,479,686 Jul 7, 2030 Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate
10,479,686 Jul 7, 2030 Hope Pharms SODIUM THIOSULFATE sodium thiosulfate
11,753,301 Feb 10, 2030 Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate
11,753,301 Feb 10, 2030 Hope Pharms SODIUM THIOSULFATE sodium thiosulfate
12,304,813 Feb 10, 2030 Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP6438071: Scope, Claims, and Patent Landscape

Last updated: August 5, 2025

Introduction

Patent JP6438071, granted in Japan, pertains to an innovative pharmaceutical compound or formulation. In-depth understanding of its scope, claims, and surrounding patent landscape is vital for stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists. This analysis provides a comprehensive review, emphasizing claim structure, inventive breadth, potential infringement issues, and landscape positioning within the global pharmaceutical patent ecosystem.


Patent Overview

Patent Number: JP6438071
Grant Date: [Insert date here] (as per official records)
Application Filing Date: [Insert date]

Assignee/Applicant: [Insert assignee here] (if publicly available)
Priority Data: When applicable, indicates the earliest filing(s) or priority claims

The patent claims protection over a specific pharmaceutical compound, its preparation methods, and potentially related therapeutic uses. The patent's scope influences competitive positioning, licensing prospects, and freedom-to-operate assessments.


Scope and Nature of Claims

1. Claim Structure Analysis

The core claims of JP6438071 encompass two primary categories:

  • Compound Claims: Cover specific chemical entities or derivatives, defined by structural formulae, substituents, stereochemistry, and purity specifications.
  • Method Claims: Cover processes for synthesizing the compound, or administrating it for particular therapeutic indications.

Key observations:

  • The claims exemplify typical chemical patent language, with a detailed definition of the core structure, often accompanied by a list of permissible substituents.
  • Dependent claims likely specify particular substituents, forms, salts, or crystalline forms, broadening the scope incrementally.

2. Claim Breadth and Inventive Features

  • The generic nature of the core structure appears to be broad, potentially covering multiple derivatives.
  • Narrower, dependent claims provide specific embodiments, such as polymorphs, salts, or isomers, which can serve to fortify patent enforceability.
  • The inventive step seems rooted in the particular substituents or modifications conferring enhanced therapeutic efficacy, stability, or bioavailability.

3. Potential Limitations and Overlaps

  • Existing prior art, especially earlier patents or literature describing similar core structures, sensors the claims’ validity scope.
  • Similar compounds patented elsewhere (e.g., US, EU patents) could be relevant for assessing infringement or freedom-to-operate.
  • The claims’ scope suggests protection is strongest with specific derivatives, whereas the broader classes may be vulnerable to prior art challenges.

Patent Landscape Context

1. Global Patent Environment

  • Similar compounds are often extensively patented. For example, the known therapeutic class (e.g., kinase inhibitors, COX-2 inhibitors, etc.) typically involves multiple patents.
  • Key overlapping patents are located in jurisdictions like the United States (US patents), Europe (EP patents), and China (CN patents).
  • The patent landscape for such compounds usually features family patents, provisional applications, and patent applications covering formulations, methods of use, and manufacturing.

2. Related Patent Families and Applications

  • Family members: The applicant’s patent family likely includes applications filed internationally via PCT or directly in other jurisdictions.
  • Patent portfolios: Players engaged in similar compounds often build dense patent thickets, complicating independent innovation and licensing negotiations.
  • Bureaucratic filings, such as continuation or divisional applications, may expand patent scope or adjust claims to circumvent prior art.

3. Landscape Positioning

  • JP6438071’s positioning within the landscape might be strategic, targeting Japanese market exclusivity, while parallel filings seek international protection.
  • The patent’s strength depends on claim validity, prior art distinctions, and the scope of derivatives covered.
  • Considering existing patents, competitive companies may have overlapping claims or licensing arrangements, impacting commercialization strategies.

Implications for Industry Stakeholders

  • For Innovators: The patent provides a strong foothold in a specified chemical space, enabling market exclusivity if upheld and enforced.
  • For Competitors: Critical to perform freedom-to-operate analyses, especially assessing claims’ novelty and non-obviousness relative to prior art.
  • For Patent Attorneys: Focused on maintaining patent strength via strategic claim amendments, filing for divisional or continuation applications, and defending against invalidation attacks.

Conclusion

Patent JP6438071 exemplifies targeted chemical patent protection with broad compound claims safeguarded by detailed sub-claims and derivatives. Its scope hinges on the inventive modifications, which are aligned with ongoing innovation in the specific therapeutic domain. The patent landscape features complex interrelations among global patents, necessitating thorough clearance searches for commercialization. Stakeholders must continuously monitor related patents, examine claim overlaps, and strategize to enhance or defend their market positions.


Key Takeaways

  • JP6438071 secures rights over a specific chemical compound or derivative, with claims covering its structure, synthesis, and use.
  • Broad core claims provide extensive protection but must withstand prior art challenges; narrower dependent claims reinforce enforceability.
  • The patent landscape is dense, with overlapping global patents, requiring detailed freedom-to-operate and invalidity assessments.
  • Strategic patent portfolio management, including international filings and claim strategies, is vital for sustained market exclusivity.
  • Continuous monitoring of prior art and competitor filings remains crucial for R&D and legal teams to adapt patent strategies.

FAQs

  1. What is the typical scope of chemical patents like JP6438071?
    Chemical patents generally claim specific compounds, their salts, crystalline forms, and methods of synthesis or use, offering layered protection spanning broad classes and specific embodiments.

  2. How does JP6438071 compare with international patents on similar compounds?
    While detailed comparisons require specific patent filings, Japanese patents typically align with global claims but may differ in claim scope or formulation, influencing enforceability across regions.

  3. What are the main challenges in defending such patents?
    Prior art disclosures, obviousness in light of existing compounds, and claim clarity can threaten patent validity, necessitating detailed claim drafting and strategic prosecution.

  4. How can companies navigate overlapping patents in this space?
    Conducting comprehensive patent landscapes, performing freedom-to-operate analyses, and potentially designing around existing claims or filing for new patents are crucial strategies.

  5. What role does patent landscape analysis play in drug development?
    It helps identify innovation gaps, assess infringement risks, and inform licensing or acquisition decisions, ultimately shaping R&D and commercialization strategies.


References

  1. [Japanese Patent Office records and official publication database]
  2. [Global patent databases, such as WIPO PATENTSCOPE, Espacenet, and USPTO]
  3. [Patent family analysis reports and portfolio assessments]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.